期刊文献+

凋亡相关分子血清可溶性Fas与不完全川崎病的关联研究 被引量:3

Study on the association of apoptosis-related molecule serum-soluble Fas with incomplete Kawasakidiseases
原文传递
导出
摘要 目的观察急性期川崎病(KD)、不完全川崎病(IKD)患儿和正常对照组3组之间的血清可溶性Fas(sFas)的表达水平,探讨sFas与IKD患儿的关联作用。方法选取本院住院治疗的急性期KD和急性期IKD患儿各32例,正常对照组20例,各组采用双抗夹心酶联免疫吸附试验(ELISA)检测血清sFas的含量,并行超声心动图检查,比较其sFas与IKD患儿的关联作用。结果(1)急性期KD组和急性期IKD组血清sFas水平高于对照组[(0.54±0.20).g/L、(0.55±O.16).g/LVS(0.24±0.04)ng/L,P〈0.05];急性期KD组和急性期IKD组sFas水平高于对照组(F=29.276,P〈0.05)。(2)急性期IKD组超声心动图异常组与超声心动图正常组血清sFas水平比较差异有统计学意义[(0.65±0.19)ng/LVS(0.49±0.10)ng/L,t=3.139,P〈0.05]。KD组、IKD组sFas与PT-D、D-D、CRP、WBC均呈正相关(r=0.353—0.693,P〈0.05),与PLT无关(P〉0.05)。结论急性期IKD患儿的外周血清sFas水平呈高表达,其与急性期IKD患儿的心血管损害关系密切相关。 Objective To compare the levels of sFas in the sera among Kawasaki disease (KD), incomplete Kawasaki disease (IKD), and normal control groups, and to analyze the relationship of sFas with IKD children. Methods A total of 32 cases of acute KD and acute IKD children,and 20 cases of the control children were selected, respectively. The levels of serum sFas among three groups were measured u- sing ELISA kits. Each child among the three groups was examined by eehocardiography. Results (1)The levels of serum sFas among the three groups were [ ( 0. 54 ± 0. 20 ) ng/L in KD, ( 0. 55 ± 0. 16 ) ng,/L in IKD, and (0. 24 ± 0. 04) ng/L] in control group, respectively. The overall means of sFas in the KD and IKD groups were higher than the control group, and the differences were statistically significant( F = 29. 276, P 〈 0. 05 ). (2)The levels of serum sFas among echocardiography abnormal and normal groups were[ (0. 65 ±O. 19 )ng/L and (0. 49 ±0. 10)ng/L ], respectively; and the difference between two groups were statistical- ly significant ( t = 3. 139, P 〈 0.05 ). Conclusions The expression levels of sFas in the peripheral serum of IKD children were increased, and there was a close association of overexpression of sFas with the cardio- vascular damage in IKD children.
出处 《中国医师杂志》 CAS 2012年第6期732-735,共4页 Journal of Chinese Physician
基金 浙江省医药卫生科学研究基金资助项目(2008-B-168)
关键词 黏膜皮肤淋巴结综合征/代谢 抗原 CD95/血液 儿童 Mucocutaneous lymph node syndrome/metabolism Antigens, CD95/blood Child
  • 相关文献

参考文献14

  • 1Manlhiot C, Christie E, McCrindle BW, et al. Complete and in- complete Kawasaki disease: two sides of the same coin. Eur J Ped- iatr, 2012,171 (4) :657-662.
  • 2周晓兵,郑雪辉.不完全川崎病40例临床分析[J].中国医师杂志,2009,11(2):221-223. 被引量:1
  • 3Sudo D, Monobe Y, Yashiro M, et al. Coronary artery lesions of incomplete Kawasaki disease : a nationwide survey in Japan. Eur J Pediatr,2012,171 (4) :651-656.
  • 4狄亚珍,邱海燕,张建萍,康国贵,陈慧琴,张若松,李潮,冯意红,赵剑英.外周血淋巴细胞凋亡调控因子Fas/FasL和血清可溶性Fas与川崎病的相关性研究[J].中华风湿病学杂志,2008,12(9):635-637. 被引量:7
  • 5Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005,47 (2) :232-234.
  • 6Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int, 2005,47(6) :711-732.
  • 7Sahebari M, Hater MR, Rezaieyazdi Z, et al. CorrelatiQn between serum levels of soluble Fas ( CD95/Apo-1 ) with disease activity insystemic lupus erythematosus patients in Khorasan, Iran. Arch I- ran Med, 2010,13(2) :135-142.
  • 8Dubikov AI, Kaliniehenko SG. Small molecules regulating apopto- sis in the synovium in rheumatoid arthritis. Scand J Rheumatol, 2010,39(5) :368-372,.
  • 9Cardinal H, Brophy JM, Bogaty P, et al. Usefuhaess of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol, 2010,105 (6) :797-803.
  • 10Esen O, Agus HZ, Guler GB, et al. Relationship between circu- lating soluble Fas ligand and preexisting left ventricular hypertro- phy in the setting of left ventricular remodeling after acute myo- cardial infarction. Coron Artery Dis, 2011,22(5) :294-298.

二级参考文献36

共引文献6

同被引文献51

  • 1张永兰,杜忠东.川崎病并发冠状动脉损害的危险因素[J].国际儿科学杂志,2006,33(2):93-96. 被引量:23
  • 2Uehara R, Belay ED. Epidemiology of Kawasaki disease in asia, europe, and the united states. J Epidemiol, 2012,22 (2) :79-85.
  • 3Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005,47(2) :232-234.
  • 4Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovas- cular disease in the young, American Heart Association. Circulation, 2004,110 (17) :274-7-2771.
  • 5Straface E, Gambardella L, Metere A, et al. Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun, 2010,392 ( 3 ) :426-430.
  • 6Tsujimoto H, Takeshita S, Nakatani K, et al. Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol, 2001,126(2) :355-364.
  • 7Galeotti C, Bayry J, Kone-Pant I, et al. Kawasaki disease : aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev, 2010,9(6) :441-448.
  • 8Tawfik DS, Cowan KR, Walsh AM, et al. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production. Pediatr Allergy Immunol, 2012,23 ( 1 ) :88-95.
  • 9von Gunten S, Simon HU. Cell death modulation by intravenous immunoglobulin. J Clin Immunol, 2010,30 Suppl 1 :S24-S30.
  • 10Tsujimoto H, Takeshita S, Nakatani K, et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol, 2002,103(2) :161-168.

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部